Literature DB >> 35909630

A systematic review on the effects of nanomaterials on gut microbiota.

W Utembe1,2, N Tlotleng3, A W Kamng'ona4.   

Abstract

Some nanomaterials (NMs) have been shown to possess antimicrobial activity and cause GM dysbiosis. Since NMs are being used widely, a systematic assessment of the effects of NMs on GM is warranted. In this systematic review, a total of 46 in vivo and 22 in vitro studies were retrieved from databases and search engines including Science-Direct, Pubmed and Google scholar. Criteria for assessment of studies included use of in vitro or in vivo studies, characterization of NMs, use of single or multiple doses as well as consistency of results. GM dysbiosis has been studied most widely on TiO2, Ag, Zn-based NMs. There was moderate evidence for GM dysbiosis caused by Zn- and Cu-based NMs, Cu-loaded chitosan NPs and Ag NMs, and anatase TiO2 NPs, as well as low evidence for SWCNTs, nanocellulose, SiO2, Se, nanoplastics, CeO2, MoO3 and graphene-based NMs. Most studies indicate adverse effects of NMs towards GM. However, more work is required to elucidate the differences on the reported effects of NM by type and sex of organisms, size, shape and surface properties of NMs as well as effects of exposure to mixtures of NMs. For consistency and better agreement among studies on GM dysbiosis, there is need for internationally agreed protocols on, inter alia, characterization of NMs, dosing (amounts, frequency and duration), use of sonication, test systems (both in vitro and in vivo), including oxygen levels for in vitro models.
© 2022 The Author(s).

Entities:  

Keywords:  Dysbiosis; Exposure; Gut microbiota; Metabolic disease; Nanomaterials

Year:  2022        PMID: 35909630      PMCID: PMC9325792          DOI: 10.1016/j.crmicr.2022.100118

Source DB:  PubMed          Journal:  Curr Res Microb Sci        ISSN: 2666-5174


Introduction

Nanomaterials (NMs) are defined as materials that have structural components smaller than 100 nanometers in at least one dimension (Buzea et al., 2007). Due to unique biological and physico-chemical properties that emerge at the nanoscale (RS and RAE, 2004), NMs have found many applications in medicines, food, pesticides electronics, textiles and many others. However, NMs can penetrate human skin, lungs and the gastro-intestinal tract and translocate into systemic circulation and eventually to tissues and organs (Nemmar et al., 2002; Bachler et al., 2015). Moreover, NMs may have indirect adverse effects on humans through modification of gut microbiota (GM), which play many indispensable roles in human health, including metabolism (Rowland et al., 2018), immunity (Geuking et al., 2014), neurobehavioral processes (MacFabe, 2012) and many others. The disturbance of normal GM configuration, often referred to as GM dysbiosis, has been linked with several human diseases and conditions, including, inter alia, asthma (Johnson and Ownby, 2017), diabetes and obesity (Moreno-Indias et al., 2014), colon cancer (Garrett, 2019), inflammatory bowel disease (IBD) (Garrett, 2019) as well as central nervous system disorders (Carabotti et al., 2015; Chin-Chan et al., 2015; Zhu et al., 2017). Titanium dioxide (TiO2), starch and silicon dioxide (SiO2) NMs are often intentionally added in food (Dekkers et al., 2011; Weir et al., 2012b; Chen et al., 2017b), while silver NPs (AgNPs), nano-clay, zinc oxide (ZnO) NPs, TiO2 are often used in food packaging because of their antimicrobial properties (Bumbudsanpharoke et al., 2015; Radusin et al., 2016). For example, the estimated mean intake of TiO2 NPs for the Dutch population ranged from 0.19 mg/kg bw/day in elderly people, 0.55 mg/kg bw/day for 7–69-year olds, to 2.16 mg/kg bw/day in young children (Rompelberg et al., 2016). Furthermore, use of number of NMs in medical formulations, including liposomes, organic polymers, micelles, metals/metal oxides, carbon nanotubes (CNTs) and other inorganic materials, may result to significant exposure of NMs to the human gut. The human gut can also be exposed to NMs from other routes other than the oral route. For example, negative effects on GM are expected to result from ingested NMs from mucociliary clearance of inhaled NMs (Pietroiusti et al., 2017) as well as intravenous injections. As an example of the latter, Lee et al. (2012) detected considerable fecal excretion of Ag NPs in rats following intravenous administration. Various investigations are yielding results on the effects of NMs on GM. However, in certain cases, these studies, which usually employ a variety of methods and approaches, appear to yield contradictory results for the same type of NM. Despite the fact that a number of narrative reviews have been done on the subject, such as those by Bouwmeester et al. (2018), Lamas et al. (2020), and Zhang et al. (2020), a systematic assessment of the evidence of the impacts of NMs on GM in various species is required.

Methods

Scientific manuscripts published from 2010 to 2020 were identified from electronic search engines such as Pubmed, Google scholar, and ScienceDirect, using terms that included ‘nanomaterials’, ‘nanoparticles’, ‘ultrafine particles’, ‘gut microbiota’, ‘commensal gut microorganisms’, ‘commensal gut microbiota’. The electronic searches were complemented by snowballing. The PECO (Population, Exposure Comparator and Outcome) strategy was used (Hoffmann et al., 2017): Experimental studies using GM (P), NMs (E) and control groups (C) were evaluated to identify the presence or absence of negative effects (O).

Characteristics and quality of included studies

Risk of bias was reduced by involvement of three independent researchers to assess the eligibility of studies. All the included studies had to involve the assessment of the adverse effects of NMs on GM, in vivo or in an in vitro system. Failure to meet this requirement resulted in the automatic exclusion of the study. However, some methods and study designs were considered more relevant than others for evaluating the effects of NMs on GM. For example, studies conducted in vivo would be considered to provide more reliable evidence than those conducted in vitro (ex vivo) because of the inherent limitations associated with in vitro studies (Pearce et al., 2018). In addition, a study using one dose level would be considered less effective than those that use more than one dose levels, since a proof of a biological gradient or dose-response is among the Braford-Hill criteria of causality (Swaen and van Amelsvoort, 2009). This is useful in this assessment even though the study is not attempting to prove causality. The use of negative controls would detect both suspected and unsuspected sources of spurious causal inferences (Lipsitch et al., 2010). While a negative control does not trigger a response, the evidence can be enhanced by the use of a positive control which triggers a response from the baseline in the expected direction and to a defined extent (Leist et al., 2010). Use of a positive control in the study assessing effects of NMs on GM would be used as an indicator for performance and sensitivity of the test system (Hothorn, 2014). The toxicological properties of NMs are often affected by their physico-chemical properties. Therefore, characterization of these properties is of fundamental importance in nanotoxicology. However, since different techniques for characterizing physico-chemical properties of NMs have strengths and limitations, more than one method is required to characterize o nano-specific properties such as size and morphology. The criteria used in this study are presented in Table 1 below.
Table 1

Criteria for the assessment of the strength of the included studies

ScoreDescription
1In vitro (ex vivo) studies using one dose level together with a negative control, without adequate characterization of NMs
2In vitro (ex vivo) studies with one dose level together with a negative control and positive control as well as adequate characterization of NMs or in vivo studies using one dose level together with a positive and/or negative control without adequate characterization of NMs
3In vitro (ex vivo) studies using multiple dose levels together with a negative and/or positive control as well as adequate characterization of NMs or in vivo studies using one dose levels together with a positive and/or negative control as well as adequate characterization of NMs
4In vivo studies using multiple dose levels together with a negative and/or control with minimal characterization of NMs
5In vivo studies using multiple dose levels together with a negative and/or positive control as well as adequate characterization of NMs
Criteria for the assessment of the strength of the included studies As shown in Table 2, the quality of evidence for each conclusion statement was rated as low, moderate, or high, depending on the confidence of the results on the effects of specific NMs on GM. The quality rating was based on the strength of the outcome in the studies behind the conclusion as well as the consistency of the results across similar studies.
Table 2

Significance of the quality of evidence for conclusion statements (adapted from Debia et al. (2016)

QualityDescription
HighStrong evidence from numerous studies with consistent results. Further studies are unlikely to change the confidence in the conclusion statement
ModerateOverall moderately to highly strong evidence and/or possible inconsistency in results. Further studies may change the confidence in the conclusion statement
LowOverall weak evidence or inconsistency in results from a limited number of studies. Further research is very likely to change the confidence in the conclusion statement: based on
Significance of the quality of evidence for conclusion statements (adapted from Debia et al. (2016)

Results

After excluding review articles, books and studies that did not assess impact or effect of NM on GM, a total of 68 journal articles were identified (46 from Google scholar, PubMed and Science Direct, as well as a further 20 articles from snowballing) (Figure 1).
Fig. 1

Flow Diagram of Study Selection

Flow Diagram of Study Selection

Effect of nanomaterials on gut microbiota

In vivo studies

Effect of NMs on the gut microbiota of model organisms

Carbon-based NMs have been shown to have significant effects on GM in model animals such as mice and rats. As an example, oral administration of 0.05, 0.5, and 2.5 mg/kg bw day single-walled carbon nanotubes (SWCNTs) for 7 days caused a metabolic inflammation response together with an increase in the abundance of proinflammatory bacteria Alitipes_uncultured_bacterium and Lachnospiraceae bacterium A4 (Chen et al., 2018a). On the other hand, 10 weeks repeated oral exposure to multi-walled carbon nanotubes (MWCNTs; 4 or- 40 mg/week) did not cause changes in the composition of GM in mice (Christophersen et al., 2016). Other carbon-based NMs that have been studied include graphene, which had greater effects on Gram-positive bacteria than Gram-negative bacteria in mice (Xie et al., 2016), as well as fullerenol (Li et al., 2018a), fullerenes (Đurašević et al., 2020), nanofibrils (nanocellulose) (Khare et al., 2020), Chitin nanofibers (CNFs) (Azuma et al., 2015) and Cu-loaded chitosan NPs (Han et al., 2010). The results of these studies are summarized in Table 3.
Table 3

Summary of effects of NMs on GM from in vivo tests

NanomaterialSpeciesExposureEffects on GMEvidence scoreReference
SWCNTs(1.04 – 1.17nm x 1-5 µm)MiceOral administration of 0, 0.05, 0.5, and 2.5 mg/kg bwt/d for 7 daysDose-dependent increases in the abundance of proinflammatory bacteria as well as significant shifts of Firmicutes5Chen et al. (2018a).
MWCNTs (49-74 nm x 3.86-5.7 µm)MiceOral and pulmonary administration of 0, 4, 40 mg/week for 10 weeksNo changes in the composition of GM4Christophersen et al. (2016)
Fullerenol 100 nm and 90 nmMice0 and 20 mg/kg per day by gavage, for a monthA shift in the overall structure of GM; a marked increase in bacteria belonging to putative SCFAs-producing genera3Li et al. (2018a).
Fullerenes (size not stated)RatsDietary 0 and 5 mg/kg b.w day, 12 weeksShift in GM structure towards the bacteria that ameliorate lipid homeostasis2Đurašević et al. (2020).
Nanocellulose (50 nm)Rats0 or 10 ml/kg bw of 1% twice weekly for five weeks by gavageEnrichment of specific species and reductions in populations of species that produce large amounts of SCFAs3Khare et al. (2020).
TiO2 (29 nm anatase)RatsOral administration of 0, 2, 10, 50 mg/ kg daily for 30 daysDose-dependent GM dysbiosis5Chen et al. (2019a).
TiO2 (29 nm anatase nm)RatsOral administration of 0, 2, 10, 50 mg/ kg daily for 90 daysDose-dependent increases in the abundance of Lactobacillus_reuteri and a decrease in the abundance of Romboutsia)5Chen et al. (2019b).
TiO2 (anatase 16.8 nmMice0, 2.5 mg/kg bw/day for 7 days by oral gavageNo obvious GM dysbiosis3Chen et al. (2017a)
TiO2 (220 nm and 255 nm, 85% anatase, 15% rutile)Rats0, 10 mg/kg bw/day for 7 days by intragastric gavageNo obvious GM dysbiosis3Talbot et al. (2018)
Rutile (16, 148, and 361 nm) and anatase (20, 135 and 420 nm)TiO2Mice0, 100 mg/kg/day for 28 days by gavageMore pronounced shift in GM structures for rutile3Li et al. (2018b)
30 nm TiO2 NPs (majority anatase)Mice0, 40 mg/kg by oral gavage for 8 weeksChanges in composition of GM3Zhu et al. (2020).
Food-grade TiO2 (28-1,158 nm)Mice0, 2, 10 and 50 mg/kg/day in drinking water for 4 weeksMinimal impact on the composition of GM.5Pinget et al. (2019).
TiO2 (10 nm primary size, undefined crystal structure)Zebra fishThree months exposure to aquatic 100 µg/L TiO2 NPs and BPA (0, 2, and 20 µg/L)Antagonistic interaction at the lower BPA concentration but synergistic interaction at higher BPA concentrations.2Chen et al. (2018b)
TiO2 NPs (10-65 nm mixed anatase and rutile)M. hemolymphAquatic 0, 100 μg/L for 4 daysDecreases in the abundance of some genera but increases in others3Auguste et al. (2019)
TiO2 (anatase, 10, 50, and 100 nm)MiceDietary exposure of 0.1% for 3 months, ad libitumSignificant decrease in the abundance of several probiotic taxa3Mu et al. (2019)
TiO2 NPs (anatase <100 nm)MiceOral 1 mg/kg bw /day for 7 daysAltered GM composition including a reduced richness of Bifidobacterium3Li et al. (2019b)
TiO2 NPs (food-grade from chocolates)White albino miceIngestion of 0, 50 and 100 µg/day for 18 daysInhibited growth and activity of probiotic formulation of B. coagulans, E. faecalis, and E. faecium5Khan et al. (2019)
TiO2 NPs (6–10 nm anatase)Silkworm (Bombyx mori)Ingestion of 0 and 5 mg/LChanges in the abundance of individual bacterial species3Li et al. (2020)
Ag (12.2 nm)MiceOral gavage of 0, 2.5 mg/kg bw/day for 7 daysShifts in inter- and intra- phyla abundance of Bacteroidetes and Firmicutes3Chen et al. (2017a)
Ag (55 nm)MiceDietary 0-4600 ppb (0-1140 µg/kg b.w./d) for 28 daysDisturbance in α-diversity) and β-diversity5Van Den Brûle et al. (2015)
Ag (50 nm nanosheres and 45 nm nanocubes) coated with PVPRatsOral administration of 0, 3.6 mg/kg b.w./day for two weeksNanocubes caused decreases in Clostridium spp., B. uniformis, Christensenellaceae, and C. eutactus; nanospheres caused decreases in Oscillospira spp., Dehalobacterium spp., Peptococcaeceae, Corynebacterium spp., Aggregatibacter pneumotropica;3Javurek et al. (2017)
Ag NPs (10, 75 and 110 nm)RatsOral gavage of 0, 9, 18 and 36 mg/kg bw/day for 13 weeksSize- and dose-dependent changes to ileal mucosal microbial populations, as well as an apparent decrease in Firmicutes phyla5Williams et al. (2015)
Ag NPs (20 and 110 nm PVP and citrate-coated)MiceOral gavage of 0, 10 mg/kg bw/day for 28 daysNo effect on the membership, structure, or diversity of GM3Wilding et al. (2016)
Ag NPs (<100 nm)Zebra fish0, 500 mg/kg in food for 14 daysMinor changes in community richness and diversity as the controls3Merrifield et al. (2013)
Ag NPs (14 nm, PVP stabilized)RatsOral gavage of 0, 2.25, 4.5 or 9 mg/kg bw/day for 28 daysNo effect on the balance between the two main phyla of gastrointestinal tract bacteria, Firmicutes and Bacteriodetes.5Hadrup et al. (2012)
Ag NPs (55 nm)Zebra fishAquatic Ag NPs (0, 10, 33 or 100 μg L−1) for 35 days.Significantly altered GM compositions in male zebrafish, but not in females5Ma et al. (2018)
Ag NPsDrosophila melanogasterVarying aquatic doses from 10 μg/ml to 9000 μg/mLReduction in the diversity of the GM of larvae with a rise in the predominance of Lactobacillus brevis and a decrease in Acetobacter compared to control5Han et al. (2014)
Ag NPsLepidopteran pest Spodoptera lituraAquatic 1.0, 0.1, 0.01 and 0.001 g/mL for 21 daysVery significant reductions in Klebsiella pneumoniae, Bacillus licheniformis, Bacillus cereus and Citrobacter freundi, Enterobacter cloacae5Bharani and Namasivayam (2017).
Ag NPsEarth worm E. fetida0, 10, 26, 64, 160 and 400 mg/kg dry soilsignificant negative effect on the relative abundance of Firmicutes and Patescibacteria; Significant positive effect on the relative abundance of Bacteroidetes5Swart et al. (2020b)
Ag NMs (from a water filtration system)Mice0.2 mL per day for 45 days by ingestionIncrease in the relative abundance of Bacteroidetes in the faeces of females and decrease in the relative abundance of Firmicutes3Wu et al. (2020)
ZnO NPs (<50 nm)Mice0, 26 mg/kg inter-gastric administration for 30 daysMarked changes in GM composition that was closely associated with neurobehavioral impairments and dysfunctions.3Chen et al. (2020).
ZnO NPs (23.0) nm,PigDietary 0, 600, 2000 mg/kg for 14 days.Increases in the bacterial richness and diversity in ileum, with decreased bacterial richness and diversity in cecum and colon;5Xia et al. (2017)
ZnO NPs (30 nm)ChickenDietary 0, 25, 50 and 100 mg/kg for 9 weeks.Dose-dependent changes in bacterial richness, metabolism of glucose and some amino acids as well as choline, lactate, and methionine5Feng et al. (2017)
ZnO NPs (30 nmC carpio.Dietary 0 and 500 mg kg−1 ZnO NPs for 6 weeksNo significant effects on the intestinal microbial community2Chupani et al. (2019)
HAHp (3.0) and ZnO NPsMiceOral administration of 0 and 1.0 g/kg bw for14 daysIncreases in the abundances of Firmicutes and reduced abundances of Bacteriodetes in female mice; enrichment of probiotic-type bacteria in the feces of female mice2Song et al. (2018)
Zn NPs (90 nm)ChickenDietary 0, 5 mg/kg of feed for 28 daysIncrease in Bacteroides and Faecalibacterium; decrease in Lactobacillus2Yausheva et al. (2018)
Zn NPs (30 nm)Mice0, 0.5, 5, 50 mg/kg in feed for 5 daysAmelioration of GM composition responsible for in initiating and maintaining IBD3Li et al. (2017)
Zn/Cu alloy NPs (65 nm)Chicken0, 2.84 mg/kg of feed for 42 daysA slight increase in the bacteria belonging to taxa Bacteroidetes and a decrease in Firmicutes2Yausheva et al. (2018)
SiO2 NPs (11 nm)MiceOral gavage 0, 2.5 mg/kg bw/day for 7 daysIncreased microbial species richness and diversity within the intestinal tract3Chen et al. (2017a).
SiO2 NPs (49 nm)MiceOral administration 0, 5.0 mg/kg b.w. one every two days for five weeksGM dysbiosis that reportedly promoted lung epithelial damage by triggering the Notch pathway3Ju et al. (2020)
Fe NPs (50 nm)Chicken0, 8 mg/kg of feed for 28 daysNo significant changes in GM2Yausheva et al. (2018)
Iron(III) oxo-hydroxidenano (10-nm)Rats20 mg Fe/kg diet as Fe(II) sulfate or 20 mg Fe/kg diet as nano Fe(III).Increase in the proportion of Lactobacillus spp. and a decrease in Bacteroides spp.2Pereira et al. (2014)
CuO NPsCollembolans0, 100 mg Cu/kg dry soilReduction in both diversity and abundance of GM as well as gut-associated ARGs2Chen et al. (2018b).
CuO NPs (183 nm)Earth worms E. fetida0, 160 mg/kg dw soil, 28 daysNegative effect on the relative abundance of C. Lumbricincola’ and positive effect on Aeromonas.3Swart et al. (2020b)
CuO NPs (20 and 50 nm)Earth worm E. fetida0, 10, 26, 64, 160 and 400 mg/kg dry soilThe alpha-diversity of treated replicates was different from the controls5Swart et al. (2020a)
CuO NPs (<50 nm)Enchytraeus crypticus0 and 100 mg Cu/ kg soil (dry weight). For 21 daysMarked increases in the alpha-diversity as well as shifts in GM communities,2Ma et al. (2020)
Cu NPs (55 nm)Chicken0, 1.7 mg/kg of feed for 28 daysA decrease in Blautia2Yausheva et al. (2018)
Cu NPs (87nm nm)Zebra fish0, 500 mg/kg in food for 14 daysSuppression of beneficial bacterial strains such as C. somerae3Merrifield et al. (2013)
MoO3 NPs (92 nm)Zebra fishAquatic 0.2 and 0.4 mg/dm3 for 7 daysChanges in intestinal GM diversity5Aleshina et al. (2020)
Se NPs (size not indicated)Chicken0, 0.3, 0.9 and 1.5 mg/kg in feedIncreases in the abundance of beneficial bacteria, such as Lactobacillus and Faecalibacterium5Gangadoo et al. (2018)
GR (0.5 µm x 1.6 nm) GO nanosheet (0.3 µm x 1.76 nm) and rGO (42 nm x 13 nm)Zebra fish.0, 1 µg /day for 21 days, dietary exposureIncreases in the relative abundance of Fusobacteria and the genus Cetobacterium and Lactobacillus, but decreases in Firmicutes and Pseudomonas3Zheng et al. (2019).
GrapheneRatsDietary 1, 10 and 100 μg/dayChanges in GM diversity and community structure, with greater effects at 1 μg/day than at 10 μg/day and 100 μg/day,5Xie et al. (2016)
GO (321.74 nm x 0-1.2 nm)Zebra fish.Aquatic 0.05, 0.5, and 5 mg L−1 for 25 daysDisruption of GM diversity at both phylum and genus levels, with notable increases in pathogenic bacteria,5Jia et al. (2019)
Nano-polystyrene (nanoplastic, 100 nm)Marine fish Larimichthys croceaAquatic 14-day exposure (0, 5.50 × 10−12, 5.50 × 10−9, 5.50 × 10−7 mg/L)Significant changes in the proportions of Bacteroidetes, Proteobacteria and Firmicutes, as well as significant increases in potentially pathogenic Parabacteroides and Alistipes4Gu et al. (2020).
Nano-polystyrene (50 – 100 nm)Soil oligochaete Enchytraeus crypticus10% soil (dry weight basis)Significant decreases in the relative abundance of Rhizobiaceae, Xanthobacteraceae and Isosphaeraceae but an increase in Amoebophilaceae2Zhu et al. (2018).
Nano-sized plastics (44 nm)ShrimpAquatic 0, 50 μg/L for 21 daysChanges in GM, amino acids and fatty acids as well as microbial activities3Chae et al. (2019)
Lead-halide perovskite NPs (889 - 1206 nm)Zebra fish24 hour aquatic exposure to 0, 5, 10, 50, 100 and 200 mg/L and dietary exposure (500 mg/kg)No significant changes in GM5Patsiou et al. (2020)
CNFs and SDA CNFsMiceOral administration 0.1% (v/v) in tap water for 28 daysIncreases in Bacteroidales as well as changes in the metabolism of acyl-carnitines and fatty acids3Azuma et al. (2015).
Cu-loaded chitosan NPsRatsDietary 80 and 160 mg/kg bw administered for 21 daysIncrease of caecal Bifidobacteria and Lactobacillus but decrease of total aerobes, total anaerobes, Clostridium, Salmonella and coliforms4Han et al. (2010)
Cu-loaded chitosan NPsPigs100 mg/kg in feedA significant decrease in the abundance of E. coli in duodenum, jejunal, and caecum as well as an increase in the abundance of lactobacillus and bifidobacterium3Wang et al. (2012)
Citral-loaded nanostructured systemsSilver catfish (Rhamdia quelen).Dietary 0.25 g/kg for 21 daysReduced total bacterial population in the fish intestine,3Sutili et al. (2019)
Summary of effects of NMs on GM from in vivo tests Metal-based NMs have also been reported to cause GM dysbiosis. For example, daily oral administration of 0, 2, 10, 50 mg/kg anatase TiO2 NPs (29 nm) to rats for 30 days could induce GM dysbiosis such as increase in L. gasseri, Turicibacter, and L. NK4A136_group and a decrease in Veillonella (Chen et al., 2019a). An extension of the exposure period from 30 days to 90 days significantly affected the diversity of GM in a dose-dependent manner, by enriching Lactobacillus_reuteri and depleting Romboutsia in feces (Chen et al., 2019b). Similarly, three-month low-dose dietary exposure of 0.1% anatase TiO2 NPs to mice could interfere with the GM balance by significantly decreasing the abundance of several probiotic taxa including Bifidobacterium and Lactobacillus, even though there was no significant effect on the total abundance of GM (Mu et al., 2019). GM dysbiosis caused by TiO2 NPs was also reported by other authors (Li et al., 2018b; Khan et al., 2019; Li et al., 2019b; Zhu et al., 2020), which was in contrast to studies by Pinget et al. (2019), Chen et al. (2019a), Li et al. (2018b), where no obvious GM dysbiosis was observed. Conflicting studies were also reported on the effects of Ag NPs on GM. For example, exposure to 2.5 mg/kg bw/day for 7 days caused shifts in inter- and intra- phyla abundance of Bacteroidetes and Firmicutes, reduction in the Firmicutes/Bacteroidetes ratio, increases in the lowly abundant families of bacteria, as well as decreases in the probiotic bacteria genus Lactobacillus (Chen et al., 2017a). Similarly, 28-day exposure of 1.18 to 36 mg/kg b.w./d Ag NPs to mice, caused dose-dependent disturbance in bacterial diversity as well as an increase in the ratio between Firmicutes and Bacteroidetes phyla (Van Den Brûle et al., 2015). However, Wilding et al. (2016) could show that a 28-day repeated oral administration of 10 mg/kg bw/day 20 and 110 nm polyvinylpyrrolidone (PVP) and citrate-coated Ag NPs could not affect the membership, structure, or diversity of GM in mice. Similarly, Hadrup et al. (2012) could show that Ag NPs do not affect the balance between the two main phyla of gastrointestinal tract bacteria, Firmicutes and Bacteriodetes. A summary of the effects of GM on model organisms is presented in Table 3.

Effects of NMs on the gut microbiota of domestic animals

Several studies have been conducted in chickens. For example, Feng et al. (2017) showed that the diversity of the bacterial community was negatively correlated with increasing amounts of ZnO NPs and was significantly decreased at 100 mg/kg bw. In addition, ZnO NPs changed metabolism of glucose and some amino acids, where choline, lactate, and methionine correlated positively with bacterial richness. Negative effects of GM in chickens were reported for dietary Zn and Cu/Zn alloy NPs Yausheva et al. (2018), intra-amniotic administered ZnO NPs, TiO2 NPs and SiO2 (Kolba et al., 2020). On the other hand, Gangadoo et al. (2018) reported positive effects in chickens for selenium NPs (Se NPs) including an increase in the abundance of beneficial bacteria, such as Lactobacillus and Faecalibacterium as well as changes in SFCAs , especially butyric acid. Effects of NMs on GM have also been reported in pigs. For example, dietary administration of 150, 300, or 450 mg/kg, and 3000 mg/kg ZnO NPs for 21 days elicited beneficial effects on intestinal GM by reducing counts of E. coli in porcine cecum, colon, and rectum (Pei et al., 2019). Other NMs that caused GM dysbiosis in pigs include Cu-loaded chitosan (Wang et al., 2012).

Effects of NMs on the gut microbiota of aquatic organisms

NMs have also been shown to affect the configuration of GM in many aquatic species. For example, a 21-day dietary exposure to graphene materials, including monolayer graphene powder (GR), graphene oxide nanosheet (GO) and reduced graphene oxide powder (rGO), resulted in the increase of the abundance of Fusobacteria and the genus Cetobacterium and Lactobacillus in zebra fish (Danio rerio) (Zheng et al., 2019). Jia et al. (2019) also reported a disruption of GM configuration at both phylum and genus levels, with increases in pathogenic bacteria, caused by chronic exposure (25 days) to 0.05, 0.5, and 5 mg L−1 GO to zebrafish. Gut microbiota dysbiosis has also been reported for nano-polystyrene in Larimichthys crocea (Gu et al., 2020) as well as citral-loaded nanostructured systems comprising of nanoemulsions (NEs) and alginate NPs in silver catfish (Rhamdia quelen) (Sutili et al., 2019). A summary of all in vivo tests including effects on GM on insects and soil micrograms is presented in Table 3.

In vitro (ex vivo) studies

The toxic effects of NMs on GM have also been reported in vitro systems. For example, exposure of 10 nm ZnO, 10 nm CeO2 and 21 nm TiO2 NPs to a colon cell culture model at concentrations of 0.01 µg/L, 0.1 and 3 mg/L respectively was reported to cause non-lethal yet significant changes to the microbial community's phenotypic traits including SCFA production, sugar content of the extracellular polymeric substance, hydrophobicity and electrophoretic mobility (Taylor et al., 2015). Similarly, 25 nm food-grade TiO2 NPs tested in vitro at 100 and 250 mg/L caused minor effects on human GM, that were limited to a modest decrease in the relative abundance of the dominant Bacteroides ovatus in favor of Clostridium cocleatum (Dudefoi et al., 2017). Radziwill-Bienkowska et al. (2018) also noted that food-grade TiO2, which differs from the P25 Organization for Economic Co-operation and Development (OECD) reference TiO2, could induce some physiological alterations in the most sensitive species, and thus affecting GM composition and functioning. Moreover, using a laboratory-scale in vitro model human colon reactor, Waller et al. (2017) observed compositional, phenotypic, and biochemical changes in GM caused by both industrial and food-grade TiO2 NPs, with more pronounced effects elicited by the food-grade TiO2 NPs. More results of in vitro studies on GM are summarized in Table 4.
Table 4

Summary of effects of NMs on GM from in vitro (ex vivo) tests

NanomaterialTest systemEffectsEvidence scoreReference
ZnO NPs (10 nm)A continuous replicated colon containing 0.01 µg/L of ZnO for 5 daysNonlethal, significant changes to the microbial community's phenotype2Taylor et al. (2015)
CeO2 (10 nm)A continuous replicated colon containing 0.01 µg/L of CeO2 for 5 daysNonlethal, significant changes to the microbial community's phenotype2Taylor et al. (2015)
TiO2 (27 nm, 82% anatase and 18% rutile)A continuous replicated colon containing 3 mg/L of TiO2 for 5 daysNonlethal, significant changes to the microbial community's phenotype2Taylor et al. (2015)
TiO2 NPs (25 nm, undefined crystal structure)A continuous Human Gut Simulator system, 100 mg/day dose for 7 daysModest reduction in community density with no impact on community diversity and evenness.2Agans et al. (2019)
TiO2 NPs (food-grade, 25 nm)In vitro static culture at a concentration of 100 and 250 mg/LA modest decrease in the relative abundance of the dominant Bacteroides ovatus in favor of Clostridium cocleatum3Dudefoi et al. (2017)
TiO2 NPs (food-grade)In vitro static culture at a concentration of 32, 62.5, 125, 320 mg/mL.Induction of some physiological alterations in the most sensitive species, and thus affecting GM composition and functioning.3Radziwill-Bienkowska et al. (2018)
TiO2 NPs (Food-grade isolated from chocolates) (40 nm)125–250 μg/ml for 48 hoursInhibited the growth and activity of probiotic formulation of Bacillus coagulans, Enterococcus faecalis, and Enterococcus faecium2Khan et al. (2019).
TiO2 NPs (industrial -252 nm, 75% anatase and 25% rutile-and food-grade- 212 nm, 98% anatase and 2% rutile)In vitro model human colon reactor, 36 mg/.dayCompositional, phenotypic, and biochemical changes in GM caused by both industrial and food-grade TiO2 NPs, with more pronounced effects elicited by the food-grade TiO2 NPs.2Waller et al. (2017)
Se NPs (unknown size)In vitro static culture at a concentration of 0.9 mg/kgSignificant reduction in the abundance of pathogenic E. cecorum without significant disturbance to the total GM community2Gangadoo et al. (2019)
Nanostructured lipid carriers (NLC, 211 nm)In vitro static culture, 0, 1.25, 2.5 and 5% v/vThis selective eradication of H. pylori without affecting the other tested human GM3Seabra et al. (2018)
Ag NPs (11 nm), PVP-cappedCultured GM from human stool exposed NPs at 0, 25, 100 and 200 mg/LReduction in gas production as well as changes in fatty acid methyl ester profiles2Das et al. (2014)
Ag NPs (49 nm),Static GIS1 simulator, 200 mg /mLA decrease in Bacteroides, Enterobacteriaceae, and Lactobacillus populations2Vamanu et al. (2018)
Ag NPs (10 nm), citrate cappedIn vitro static culture, 25, 50 and 100 μg/mL for 24 hoursConcentration, temperature- and time-dependent inactivation of gastrointestinal phages/virus manner3Gokulan et al. (2018)
Ag NPs (30–50 nm)Human Gut dynamic Simulator system, 100 mg/day dose for 7 daysDrastic reduction of GM population density.2Agans et al. (2019)
Ag NPs, polyethylene glycol (PEG) and glutathione (GSH) stabilizedContinuous SIMGI® simulator, 88 μg/ml of PEG-AgNPs, 20 and 61 μg/ml of GSH-Ag, for 8 daysNo significant changes in the composition and metabolic activity of GM3Cueva et al. (2019).
Ag NPs (14 nm), citrate-cappedIn vitro batch fermentation models, inoculated with human fecal matter and 1 μg/mL NPs for 24 hoursNo effect on the composition and diversity of fecal microflora and their metabolic profiles2Cattò et al. (2019)
Nanocellulose fibres (4–5 nm)In vitro static culture, 500, 250, 100 and 50 µg/mLA bacteriostatic effect of on Escherichia coli and none on Lactobacillus reuter2Lopes et al. (2020)
SWCNTs (1–3μm) and MWCNTs (> 50 μm)In vitro static culture (20, 50 100 µg/LBroad-spectrum antimicrobial activity against L. acidophilus, B. adolescentis, E. coli, E. faecalis, and S. aureus; greater antimicrobial activity for thin and rigid SWCNTs than MWCNTs.1Chen et al. (2013).
Graphene oxidein vitro static culture, 10 to 500 µg/ml for 24 hoursNo adverse effect on human intestinal gram-negative E. coli K-12 and gram-positive L. acidophilus ADH, and Bifidobacterium animalis Bif-63Nguyen et al. (2015)
Summary of effects of NMs on GM from in vitro (ex vivo) tests

Discussion

This study identified 46 studies conducted in vivo on a number of models such as mice, rats, terrestrial insects, aquatic organism, and soil organisms, as well as 22 in vitro studies including those that mimic the human digestive tract. The type and magnitude of effects of NMs on GM in various organisms generally depended on the type of NM and were likely to be affected by many experimental factors such as test organism or model, dose, route of exposure, type of adminstration (single or repeated), size of NMs, exposure duration, time points for assessment of effects, methods of characterization of physico-chemical properties as well as methods used to assess GM dysbiosis. Comparison of results from different studies was complicated by large variations in these conditions. This review could show that different NMs elicited different effects in GMs. Furthermore, different forms of the same types of NM caused different effects in some cases. For example Chen et al. (2019a) and Li et al. (2018b) reported GM dysbiosis in mice caused by TiO2 NMs, in contrast to Pinget et al. (2019), Chen et al. (2017a) and Talbot et al. (2018) who reported no obvious GM dysbiosis in murine species. However, the differences in the results reported for TiO2 may be attributed to the variations in forms of TiO2, especially the differences between food-grade and non-food grade TiO2 NPs (EFSA, 2016). It is important to note that toxicity of food-grade TiO2 to GM differs from that of the P25 OECD reference or industrial TiO2 NPs (Waller et al., 2017; Radziwill-Bienkowska et al., 2018). The contradictions in the toxicity of the two forms of TiO2 on GM were also observed in vitro (Waller et al., 2017). Contrasting results were also reported for Ag NPs both in vivo (Hadrup et al., 2012; Williams et al., 2015; Wilding et al., 2016; Javurek et al., 2017) and in vitro (Hadrup et al., 2012; Das et al., 2014; Vamanu et al., 2018; Agans et al., 2019; Cueva et al., 2019). The reasons for these differences are not clear. The mechanisms of action of Ag NPs against GM, which appear to be the release of Ag+ ions, oxidative stress, blockage of DNA replication as well as the destruction of bacterial cell membranes (Li et al., 2019a), may explain the shape-dependent differences in the effects caused by NCs and NPs as reported by Javurek et al. (2017). Nevertheless, there is need for more studies on the effects of shape of NMs on their toxicity towards GM. More studies are also required on the effects of functional groups since adverse effects of functionalized Ag NPs were reported in one in vivo (Javurek et al., 2017) and two in vitro studies (Das et al., 2014; Gokulan et al., 2018), but not in some in vivo (Hadrup et al., 2012; Wilding et al., 2016) and in vitro (Cattò et al., 2019; Cueva et al., 2019) studies. Although sex-dependent toxic effects on GM are reported for some conventional substances (Ba et al., 2017; Lozano et al., 2018), the sex-dependent effects of Ag NPs on zebrafish GM that were reported by Ma et al. (2018) and Wu et al. (2020 require further investigation. Similarly, as size-dependent effects were observed in one study only (Williams et al., 2015), there is need to assess the effects of size of NMs on toxicity towards GM. In contrast to size-dependent effects that were observed in a few studies, dose dependency was observed in many studies (Van Den Brûle et al., 2015; Williams et al., 2015; Wilding et al., 2016; Chen et al., 2018a; Chen et al., 2019a; Chen et al., 2019b). Nevertheless, there were numerous studies that only used one dose, in addition to a naïve or negative control. As discussed earlier, these studies would be less effective since proof of a dose response is needed to establish causality (Swaen and van Amelsvoort, 2009). In addition, effects assessed at one-time point may be different from those observed over time. As shown in Table 3, the majority of in vivo investigations involved NMs being administered orally (through diet or oral gavage), with fewer studies involving environmental exposure via water or soil. It is interesting to observe that environmental exposure to 10, 33 and100 μg L−1 Ag NPs (55 nm) for 35 days significantly altered GM compositions in male zebrafish (Ma et al., 2018), while dietary exposure of the same species to 500 mg/kg Ag NPs (<100 nm) for 14 days only caused minor changes in community richness and diversity (Merrifield et al., 2013). The differences in effects could not only be attributed to differences in the routes of exposure, but also differences in size of NMs and duration of exposure. Unfortunately, a comparison of the effects of route of administration could not be made in the study by Christophersen et al. (2016), which involved both oral and pulmonary exposure of MWCNTs to mice, since the authors only focused on the effects of on GM following oral exposure. In nanotoxicology, inconsistencies have been reported among both in vitro and in vivo studies because of lack of standardized dispersion protocols and lack of proper characterization of NMs (Sayes et al., 2007b; Sayes et al., 2007a; Cohen et al., 2015). The method used to disperse the NMs affects the extent of agglomeration and surface properties, which would in turn affect their toxicity. Several protocols for preparing NP dispersions prescribe levels of delivered acoustic energy to the solution and sonication times to limit agglomeration (Pradhan et al., 2016). Many authors such as Chen et al. (2018a), Ju et al. (2020), Christophersen et al. (2016), (Zhu et al., 2020) and (Pinget et al., 2019) used various sonication procedures to prepare NMs for the study of GM dysbiosis, while other authors, including Khare et al. (2020), Li et al. (2018a), Li et al. (2018b), and Mu et al. (2019) did not report the use of any sonication procedures. Since variations in dispersion procedures could affect results among similar NMs, use of standard protocols, such as the one proposed by DeLoid et al. (2017), cannot be overemphasized. Standard protocols are also required for assessing the physico-chemical properties that affect the toxicological properties of NMs, including inter alia size, shape, surface area, charge, chirality, functional groups. Indeed, different techniques for measuring each physico-chemical property have strengths and limitations that complicate the choice of the most suitable method. For the determination of size and morphology of NMs for example, widely used techniques include transmission electron microscopy (TEM), scanning transmission electron microscopy (SEM) and dynamic light scattering (DLS). Various combinations of these techniques were used in the majority of the studies, although a few studies such as those by Chupani et al. (2019), Song et al. (2018) and Yausheva et al. (2018), did not specify the methods for characterizing the pertinent nano-specific physico-chemical properties of NMs like size, shape and surface area. Differences in techniques and methods used for characterization could indeed lead to differences in results among similar NMs. Differences in results between studies could also be attributed to differences in techniques or methods used to analyze the microbiota, especially differences in the type of samples and sites of collection, whether culture-dependent or culture-independent approaches were used, as well as differences in techniques used to analyze the microbiota (Goodrich et al., 2014; Van Den Brûle et al., 2015). As there are numerous factors involved, it is difficult to ascertain that methodological differences were responsible for differences in effects caused by a particular NM among a number of studies. Overall, the majority of the studies utilized PCR amplification of 16S rRNA for culture-independent characterization of GM configuration, with a very small number of studies using single colonies. Very high doses were used in some studies where negative effects of NMs on GM were reported. For example, Li et al. (2018b) used a dose of 100 mg TiO2 /kg/day whereas human exposure to TiO2 in the USA has been estimated at 1-2 mg/kg day for children and 0.2 – 0.7 mg/kg day in adults (Weir et al., 2012a). Similarly, although migration from food packaging has been estimated to result to dietary Ag NPs exposure of between 5.89 × 10−5 and 8.9 × 10 −5 mg/kg.day (Cushen et al., 2014), doses as high as 500 mg/kg (equivalent to 7.1 mg/kg.day in humans) were used (Merrifield et al., 2013). On the other hand, Chen et al. (2018b) claims to have exposed zebra fish to an environmentally relevant aquatic concentration of 100 µg/L of TiO2 NPs. For effective and relevant results, studies are required to estimate real-life exposure levels of NMs for humans and other species and to ascertain if these doses are sufficiently large to alter GM in a manner that can result in toxicologically significant outcomes (Utembe and Kamng'ona, 2021). Admittedly, it will be difficult to determine the exposure levels of GM to NMs through other routes other the oral route. For example, in the studies of effects of CNTs on GM, doses ranged from 0.05 to 5 mg/kg bw/d, while only small fractions of inhalable CNTs doses (4.07 μg/day 4.07 in humans and 2 ng/day in mice) are expected to be transported from the lung to the GI tract through mucociliary transport (Erdely et al., 2013). Table 3 shows large variations in the studies in terms of duration of exposure (and examination of effects) which ranged from a few days to 3 months (90 days). This important aspect makes the comparison GM dysbiosis studies very challenging. A very notable example includes studies conducted on 29 nm anatase TiO2 NMs for 30 days by Chen et al. (2019a) and the same NMs for 90 days by Chen et al. (2019b). While the TiO2 NMs are reported to have elicited dose-dependent changes on GM in both studies, the changes in specific species of GM appear to be different. Therefore, future studies should take dose frequency and duration as well as the period for the examination of the effects into consideration. For the NMs that affect GM through disruption of the cell wall, the existence or nature of cell wall is expected to influence toxicity. In that regard, Gram-negative bacteria would be expected to have higher tolerance than Gram-positive bacteria because of differences in cell wall structures. While Gram-positive bacteria possess a cytoplasmic membrane and a thick peptidoglycan layer, gram-negative bacteria possess a thick cell wall that consists of two cell membranes, an outer membrane, and a plasma membrane, as well as one thin peptidoglycan layer (Fu et al., 2005). Indeed, Xie et al. (2016) reported greater tolerance of Gram-negative bacteria towards graphene than Gram-positive bacteria. Similarly, Ag NPs cause adverse effects on Gram-negative bacteria at lower concentrations than in Gram-positive bacteria (Fröhlich and Fröhlich, 2016; Zhang et al., 2020). Nevertheless, as ZnO NPs negatively affect both groups of bacteria at similar concentrations (Fröhlich and Fröhlich, 2016), there is need for more studies on factors that contribute to the differential effects of NMs on Gram-positive and Gram-negative bacteria Some NMs affect GM through the generation of ROS which can directly damage biomolecules, including the cell wall and DNA. The generation of ROS in aerobic environments may not be similar to the generation of ROS at anaerobic conditions. Therefore, the rates and mechanisms of GM disruption at high oxygen levels may not be relevant in anaerobic or anoxic environments that prevail in some parts of the GM tracts (Zhang et al., 2020). However, the majority of in vitro studies have been conducted in aerobic conditions, and the continuous simulator cited in this paper such as those by Cueva et al. (2019), Taylor et al. (2015) and Agans et al. (2019) did not make any reference of the oxygen levels or aerobic/anaerobic conditions of the various compartments. A very important issue in the study of effects of NMs on GM involves the choice of test systems or models among in vitro and in vivo systems. Although in vitro model systems offer relatively more realistic exposure environments, while at the same time enabling higher control over experimental conditions, it is only animal models that enable studies under realistic host environment, where several bacterial phyla interact and influence each other (Zhang et al., 2020). On the other hand, although animal models seem to be the most reliable, it is important to realize that the GM in animals may be very different from human GM. Among animal models, mice are the most widely used in GM studies because they possess similar structure of gastrointestinal tract to humans (Velmurugan, 2018). In Table 3, mice appear 20 times, compared to rats that appear 11 times. Eight (8) of the studies were performed on zebrafish which is an emerging model in GM studies. Although adult mammalian GM communities are characterized by high abundances of Bacteroidetes and Firmicutes as opposed to a high abundance of Proteobacteria, Fusobacteria, and Firmicutes in zebrafish (Catron et al., 2019), studies of GM dysbiosis in zebra fish can provide useful information for humans since greater than 70% of its genes are homologous to those in humans (Howe et al., 2013). Table 3 also shows the emerging use of chickens as an animal model in GM studies, owing to increasing use of NM formulations for growth promotion (Yausheva et al., 2018). Few studies were performed on pigs, which have been recognized as a superior model compared to other non-primate models because of their physiological, metabolic and nutritional similarities with humans pigs (Heinritz et al., 2013). Indeed, the choice of test organism appear to be the source of variation among a number of studies. For example, exposure of C carpio to 500 mg kg−1 ZnO NPs (30 nm) through the diet for 6 weeks did not cause significant effects in intestinal microbial community (Chupani et al., 2019). On the other hand, exposure of chickens to a much lower dietary dose of 50 and 100 mg/kg (30 nm) ZnO NPs for 9 weeks caused dose-dependent changes in bacterial richness as well as metabolism of glucose and some amino acids (Feng et al., 2017). In in vitro or ex vivo studies, many studies assessed the direct effects of NPs on the growth and metabolism of specific monocultures of bacteria isolated from gut, using incubation conditions that mimic in vivo conditions. However, the use of isolated bacteria assesses the effects of NMs on specific species or strains of bacteria. On the contrary, the most suitable in vitro models are those that use human faeces samples, which contain realistic and more representative GM diversity. The monoculture models are still useful for assessing specific effects of NMs or for elucidating mechanisms of NM interaction with microorganisms (Campos et al., 2022). Most studies have evaluated the adverse effects of single NMs on GM under laboratory-controlled conditions, whereas real-life exposures involve mixtures of NMs. In that regard, TiO2 NPs and BPA elicited antagonistic effects at low BPA concentration and synergistic effects at high BPA concentrations (Chen et al., 2018b). Similarly, synergistic dysbiotic effects were also reported for SiO2 NPs and low dose radiation (Ju et al., 2020). Therefore, there is need to assess the combined effects of various mixtures of NMs as well as mixtures of GM and other substances on GM. This systematic review used subjective, arbitrary and potentially disputable score criteria to assess the quality of the evidence of toxicity of NMs towards GM. These indicative criteria will hopefully initiate debate and discussions, and serve as a starting point for the development of universally agreed quality assessment criteria and indicators in GM dysbiosis studies. In the end, this study has shown that for consistency and better agreement among studies on GM dysbiosis, there is need for internationally agreed protocols on, inter alia, characterization of NMs, dosing (amounts, frequency and duration), use of sonication, test systems (both in vitro and in vivo), as well as the oxygen levels on in vitro models. A summary of the quality of evidence by type of NM is presented in Table 5. While the effects of various NMs on GM can lead to many metabolic diseases, the effects offer opportunities of using these NMs as micronutrient preparations that can be used to enhance bacterial diversity and correct dysbiosis (Chen et al., 2017a; Li et al., 2017; Yausheva et al., 2018; Gangadoo et al., 2019).
Table 5

Summary of quality of evidence by type of nanomaterial

NanomaterialTotal number of in vivo studiesTotal number of ex vivo studiesGeneral comment on GM dysbiosisQuality of evidence rating
SWCNTs11Changes in GM, more studies requiredLow
MWCNTs11No changes in GM, more studies requiredLow
Fullerenes20Changes in GM, more studies requiredModerate
Nanocellulose11Changes in GM, more studies requiredLow
TiO2
Anatase70Six studies showed dysbiosis, one study showed no obvious dysbiosisModerate
Rutile10More studies requiredLow
Food-grade23Minimal or modest impact on the composition of GM. More studies requiredLow
Mixed or undefined crystal structure43Modest GM dysbiosisLow
Silver126Some studies indicate Ag NPs cause GM dysbiosis, while other indicate otherwise. Same results for functionalized NPsModerate
ZnO41Significant changes in GMModerate
Zn20Significant changes in GMModerate
Zn/Cu alloy10Slight changes in GMLow
HAHp (3.0) and ZnO NPs10Significant changes in GMLow
SiO220Changes in GM, more studies requiredLow
Fe10No significant changes in GMLow
Nanoparticulate Iron(III) oxo-hydroxidenano10Significant changes in GMLow
CuO40Significant changes in GMModerate
Cu20Significant changes in GMModerate
Se11Significant changes in GMLow
GR, GO nanosheet and rGO31Some studies indicate GM dysbiosis, others do notLow
Nano-polystyrene20Significant changes in GMModerate
Nanoplastics10Changes in GMLow
Lead-halide perovskite10No changes in GMLow
CeO201Changes in GMLow
MoO3 NPs10Significant changes in GM diversityLow
CNFs and (SDA) and CNFs10Significant changes in GM diversityLow
Cu-loaded chitosan NPs20Significant changes in GMModerate
Citral-loaded nanostructured systems comprising of nanoemulsions (NEs) and alginate NPs10Significant changes in GMLow
Citral-loaded nanostructured systems10Significant changes in GMLow
Summary of quality of evidence by type of nanomaterial

Conclusion

This systematic review has shown the potential of NMs to cause GM dysbiosis in many species as well as in humans. Overall, there was moderate evidence for GM dysbiosis caused by Zn-based NMs, Ag NPs, Cu-based NMs, Cu-loaded chitosan NPs and anatase TiO2 NPs. Effects of various NMs on GM in humans and other animals present opportunities for using in the treatment of GM dysbiosis-related illnesses and conditions. The effects of NMs on GM varied depending on the NM type and organism. Some NMs, particularly TiO2 and Ag, produced contradictory outcomes both in vivo and in vitro. As a result, more research into the effects of NM size on GM toxicity is required. More research into the effects of form, functional groups, and other physico-chemical properties is also needed. The effects of concurrent exposure to combinations of NMs on GM must also be evaluated. For consistency and better agreement among studies on GM dysbiosis, there is need for internationally agreed protocols on, inter alia, characterization of NMs, dosing (amounts, frequency and duration), use of sonication, test systems (both in vitro and in vivo), as well as the levels of oxygen for in vitro models.

Disclaimer

The article has been prepared in the authors’ own capacity. The opinions, findings and conclusions in this article are therefore the authors’ own and do not necessarily reflect or represent the views of the Kamuzu University of Health Sciences, the National Institute for Occupational Health (NIOH), the national Health Laboratory Service (NHLS) or the University of Johannesburg.

Author contributions

W.U, N.T. and A.W.K. were all involved in literature search, writing and editing of the manuscript.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  100 in total

1.  Evaluation and simulation of silver and copper nanoparticle migration from polyethylene nanocomposites to food and an associated exposure assessment.

Authors:  M Cushen; J Kerry; M Morris; M Cruz-Romero; E Cummins
Journal:  J Agric Food Chem       Date:  2014-01-31       Impact factor: 5.279

2.  Effects of dietary zinc oxide nanoparticles supplementation on growth performance, zinc status, intestinal morphology, microflora population, and immune response in weaned pigs.

Authors:  Xun Pei; Zhiping Xiao; Lujie Liu; Geng Wang; Wenjing Tao; Minqi Wang; Junbiao Zou; Dongbi Leng
Journal:  J Sci Food Agric       Date:  2018-10-17       Impact factor: 3.638

Review 3.  A Systematic Review of Reported Exposure to Engineered Nanomaterials.

Authors:  Maximilien Debia; Bouchra Bakhiyi; Claude Ostiguy; Jos H Verbeek; Derk H Brouwer; Vladimir Murashov
Journal:  Ann Occup Hyg       Date:  2016-07-15

4.  Survival of probiotic bacteria in the presence of food grade nanoparticles from chocolates: an in vitro and in vivo study.

Authors:  Shams Tabrez Khan; Shaibi Saleem; Maqusood Ahamed; Javed Ahmad
Journal:  Appl Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 4.813

5.  Dysbiosis of gut microbiota by dietary exposure of three graphene-family materials in zebrafish (Danio rerio).

Authors:  Min Zheng; Jianguo Lu; Genmei Lin; Hualong Su; Jingyu Sun; Tiangang Luan
Journal:  Environ Pollut       Date:  2019-07-31       Impact factor: 8.071

6.  Dysbiosis of gut microbiota by chronic coexposure to titanium dioxide nanoparticles and bisphenol A: Implications for host health in zebrafish.

Authors:  Lianguo Chen; Yongyong Guo; Chenyan Hu; Paul K S Lam; James C W Lam; Bingsheng Zhou
Journal:  Environ Pollut       Date:  2017-12-21       Impact factor: 8.071

7.  Intestinal microbiome of broiler chickens after use of nanoparticles and metal salts.

Authors:  Еlena Yausheva; Sergey Miroshnikov; Еlena Sizova
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-24       Impact factor: 4.223

8.  Cardiovascular health effects of oral and pulmonary exposure to multi-walled carbon nanotubes in ApoE-deficient mice.

Authors:  Daniel V Christophersen; Nicklas R Jacobsen; Maria H G Andersen; Shea P Connell; Kenneth K Barfod; Morten B Thomsen; Mark R Miller; Rodger Duffin; Jens Lykkesfeldt; Ulla Vogel; Håkan Wallin; Steffen Loft; Martin Roursgaard; Peter Møller
Journal:  Toxicology       Date:  2016-10-08       Impact factor: 4.221

Review 9.  The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group.

Authors:  Antonio Pietroiusti; Enrico Bergamaschi; Marcello Campagna; Luisa Campagnolo; Giuseppe De Palma; Sergio Iavicoli; Veruscka Leso; Andrea Magrini; Michele Miragoli; Paola Pedata; Leonardo Palombi; Ivo Iavicoli
Journal:  Part Fibre Toxicol       Date:  2017-11-25       Impact factor: 9.400

10.  Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans.

Authors:  Dora I A Pereira; Sylvaine F A Bruggraber; Nuno Faria; Lynsey K Poots; Mani A Tagmount; Mohamad F Aslam; David M Frazer; Chris D Vulpe; Gregory J Anderson; Jonathan J Powell
Journal:  Nanomedicine       Date:  2014-06-28       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.